Univest Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-42,216
Closed -$3.02M 120
2019
Q4
$3.02M Buy
+42,216
New +$2.75M 1.28% 39
2017
Q1
Sell
-42,216
Closed -$3.02M 96
2016
Q4
$3.02M Buy
42,216
+741
+2% +$55.1K 1.28% 39
2016
Q3
$3.28M Buy
41,475
+590
+1% +$47.9K 1.49% 31
2016
Q2
$3.41M Sell
40,885
-451
-1% -$40K 1.56% 25
2016
Q1
$3.8M Buy
41,336
+831
+2% +$74.9K 1.73% 16
2015
Q4
$4.1M Buy
40,505
+713
+2% +$74.2K 1.87% 15
2015
Q3
$3.91M Buy
39,792
+903
+2% +$100K 1.91% 12
2015
Q2
$4.55M Sell
38,889
-1,288
-3% -$141K 2.09% 6
2015
Q1
$3.94M Sell
40,177
-426
-1% -$43.3K 1.77% 13
2014
Q4
$3.83M Buy
40,603
+902
+2% +$93.3K 1.68% 21
2014
Q3
$4.23M Sell
39,701
-3,543
-8% -$347K 1.98% 6
2014
Q2
$3.58M Sell
43,244
-163
-0.4% -$12.7K 1.69% 18
2014
Q1
$3.08M Sell
43,407
-4,019
-8% -$315K 1.53% 29
2013
Q4
$3.56M Sell
47,426
-8,415
-15% -$586K 1.76% 15
2013
Q3
$3.51M Sell
55,841
-3,625
-6% -$217K 1.87% 13
2013
Q2
$3.05M Buy
+59,466
New +$3.1M 1.67% 20

Other funds holding GILD

Univest Financial's GILD Position: Q1 2020 in Review

Univest Financial sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 42,216 shares — an estimated $3.02M sold.

Univest Financial first reported a position in GILD in Q2 2013 and held it in 16 quarters. The position peaked at $4.55M in Q2 2015. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Univest Financial reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Univest Financial sold 42,216 Gilead Sciences shares in Q1 2020, an estimated $3.02M.
  • Univest Financial first reported a position in Gilead Sciences in Q2 2013 and held it in 16 quarters.
  • Univest Financial's Gilead Sciences position peaked at $4.55M in Q2 2015.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Univest Financial's 13F filing for Q1 2020, filed 5 May 2020.